期刊
BIOORGANIC & MEDICINAL CHEMISTRY
卷 24, 期 18, 页码 4138-4143出版社
PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.bmc.2016.06.057
关键词
Alzheimer's disease; Amyloid-beta; C-terminal motif; Trolox; Aggregation inhibitor; Antioxidative activity; Cell protection
资金
- Ministry of Education, Culture, Sports, Science and Technology - Japan [26460153]
- Grants-in-Aid for Scientific Research [26111012, 26460153] Funding Source: KAKEN
Two hallmarks of Alzheimer's disease (AD) observed in the brains of patients with the disease include oxidative injury and deposition of protein aggregates comprised of amyloid-beta (A beta) variants. To inhibit these toxic processes, we synthesized antioxidant-conjugated peptides comprised of Trolox and various C-terminal motifs of Ab variants, TxA beta(x-n) (x = 34, 36, 38, 40; n = 40, 42, 43). Most of these compounds were found to exhibit anti-aggregation activities. Among them, TxA beta(36-42) significantly inhibited A beta(1-42) aggregation, showed potent antioxidant activity, and protected SH-SY5Y cells from A beta(1-42)-induced cytotoxicity. Thus, this method represents a promising strategy for developing multifunctional AD therapeutic agents. (C) 2016 Elsevier Ltd. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据